Tailoring biotech start-up solutions for the USG
Strengthening US Biosecurity through world class innovation
Tailoring biotech start-up solutions for the USG
Strengthening US Biosecurity through world class innovation
About Us
Why Us
Why Us
Why Us
Our leadership team has a unique mix of public and private leadership experience. We helped build the first civilian R&D biodefense program in the country over 20 years ago and continue to work closely with many branches of the US Government, We have a deep network of Silicon Valley biotech investors and start-ups, having been CEOs and
Our leadership team has a unique mix of public and private leadership experience. We helped build the first civilian R&D biodefense program in the country over 20 years ago and continue to work closely with many branches of the US Government, We have a deep network of Silicon Valley biotech investors and start-ups, having been CEOs and founders of companies in the AI, diagnostics, and synthetic biology spaces.
Why Us
Why Us
Why Us
Our leadership team has a unique mix of public and private leadership experience. We helped build the first civilian R&D biodefense program in the country over 20 years ago and continue to work closely with many branches of the US Government, We have a deep network of Silicon Valley biotech investors and start-ups, having been CEOs and
Our leadership team has a unique mix of public and private leadership experience. We helped build the first civilian R&D biodefense program in the country over 20 years ago and continue to work closely with many branches of the US Government, We have a deep network of Silicon Valley biotech investors and start-ups, having been CEOs and founders of companies in the AI, diagnostics, and synthetic biology spaces.
How We Help
Experience the Difference
Experience the Difference
Financing for the new biosecurity and a new bioeconomy has become a national priority over the past few years. While there are billions of dollars allocated to these new programs, much of this remains inaccessible or impractical for small biotech start-ups. Law firms and lobbyists are available to support these efforts, but lack any real
Financing for the new biosecurity and a new bioeconomy has become a national priority over the past few years. While there are billions of dollars allocated to these new programs, much of this remains inaccessible or impractical for small biotech start-ups. Law firms and lobbyists are available to support these efforts, but lack any real understanding of deep tech and are incapable of translating commercial solutions to ones tailored for the national interest. The unique DNA of our team allows us to seamlessly bridge this gap and help small companies raise USG funding with little or no distraction to their core business.
Experience the Difference
Experience the Difference
Experience the Difference
Leap Bio! stands out in the market due to our team of proven industry leading scientists and CEO level leadership who bring a wealth of knowledge and expertise to the development of our products. We have deep relationships with multiple US government agencies and understand current and evolving national level priorities in biological R&D.
Leap Bio! stands out in the market due to our team of proven industry leading scientists and CEO level leadership who bring a wealth of knowledge and expertise to the development of our products. We have deep relationships with multiple US government agencies and understand current and evolving national level priorities in biological R&D. Our team has a proven track record of finding solutions that are aligned with growing new biotech businesses and a unique operating model that sets us apart from our competition.